(19)
(11) EP 4 034 561 A2

(12)

(88) Date of publication A3:
27.05.2021

(43) Date of publication:
03.08.2022 Bulletin 2022/31

(21) Application number: 20789003.9

(22) Date of filing: 25.09.2020
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
C07K 14/725(2006.01)
 C07K 16/40(2006.01)
A61K 35/17(2015.01)
(52) Cooperative Patent Classification (CPC):
A61K 35/17; C07K 2319/33; C07K 2319/03; C07K 2317/34; C07K 2317/622; C07K 16/2896; C07K 2317/732; C07K 2317/92; A61P 11/00
(86) International application number:
PCT/EP2020/076995
(87) International publication number:
WO 2021/058795 (01.04.2021 Gazette 2021/13)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 27.09.2019 US 201916585256
27.09.2019 EP 19200182

(71) Applicant: Starkage Therapeutics
59000 Lille (FR)

(72) Inventors:
  • OGRUNC, Müge
    75010 Paris (FR)
  • MATHIEU, Thierry
    1180 Bruxelles (BE)

(74) Representative: Icosa 
83 avenue Denfert-Rochereau
75014 Paris
75014 Paris (FR)

   


(54) SENESCENT CELL-ASSOCIATED ANTIGEN-BINDING DOMAINS, ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS COMPRISING THE SAME, AND USES THEREOF